Three models of Medical King's Bed Assist Rails are being recalled due to the risk of entrapment and asphyxia.
The pharmaceutical distributor has launched InspiroGene, a business unit offering logistics and other support for ...
Zacks.com on MSN3d
Investors Heavily Search McKesson Corporation (MCK): Here is What You Need to KnowMcKesson (MCK) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term. Over the ...
It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions ...
We rate McKesson as a 'Strong Buy' with focus on GLP-1 meds, oncology network, and strong Q2 results driving future growth.
Fintel on MSN9d
Baird Upgrades McKesson (MCK)Fintel reports that on November 7, 2024, Baird upgraded their outlook for McKesson (NYSE:MCK) from Neutral to Outperform. ...
Steve Baxter, an analyst from Wells Fargo, maintained the Hold rating on McKesson (MCK – Research Report). The associated price target ...
McKesson (MCK – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Allen Lutz ...
Outside the us market, McKesson engages in pharmaceutical wholesale and distribution in Canada. Additionally, the company ...
Chicago Partners Investment Group LLC increased its stake in shares of McKesson Co. (NYSE:MCK – Free Report) by 17.0% during ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback